Home > Healthcare > Pharmaceuticals > Finished Drug Form > Gabapentin Market

Gabapentin Market Share

Report ID: GMI6722
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Gabapentin Market Share

The key players in the gabapentin market are :

Pfizer Inc.
Glenmark Pharmaceuticals Limited
Sun Pharmaceutical Industries Ltd.
Ascend Laboratories LLC
Apotex Inc.
Teva Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd.
Amneal Pharmaceuticals LLC
Cipla Inc.
BP Pharmaceuticals Laboratories Company
Assertio Holdings, Inc.
Arbor Pharmaceuticals, Inc.
Zydus Pharmaceuticals
Dr. Reddy's Laboratories Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Gabapentin market size was USD 2.1 billion in 2023 and will register 4.9% CAGR from 2024 -2032 due to the rising incidence of neuropathic pain worldwide.

The generic type segment held 79.3% share of the industry in 2022 and will incur significant growth from 2023-2032 on account of high affordability and cost effectiveness when compared to the branded counter parts.

North America industry recorded USD 786.3 million in revenue in 2022 and is expected to witness appreciable growth from 2023-2032 owing to the rising prevalence of epilepsy, and neuropathic pain along with the presence of key players in the region.

Pfizer Inc., Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Ascend Laboratories, LLC, Apotex Inc., Teva Pharmaceutical Industries Ltd., and Aurobindo Pharma Ltd., are some of the major gabapentin companies worldwide.